Welcome to our dedicated page for Star Intermediate I news (Ticker: DNB), a resource for investors and traders seeking the latest updates and insights on Star Intermediate I stock.
Dun & Bradstreet Holdings Inc. appears in company news about business decisioning data and analytics, including Data Cloud products, sales and marketing intelligence, finance and risk solutions, and integrations that place global business data inside customer workflows. Recurring developments include product launches such as healthcare-focused datasets, partnerships for private-company deal sourcing and investigative software, and scheduled financial-results communications.
Corporate-status developments also include the company's completed 2025 merger, after which Dun & Bradstreet survived as a wholly owned subsidiary of an affiliate of investment funds managed by Clearlake Capital Group L.P.
Dun & Bradstreet has successfully closed its initial public offering (IPO) of 90,047,612 shares at $22.00 per share, generating gross proceeds of approximately $2.38 billion. The IPO was completed on July 6, 2020, following its trading debut on the NYSE under ticker symbol 'DNB' on July 1, 2020. The company utilized part of the proceeds to redeem all Series A Preferred Stock and repay a portion of its Senior Unsecured Notes due in 2027. The remaining funds will be used as outlined in the IPO prospectus.
Dun & Bradstreet announced the pricing of its initial public offering (IPO) of 78,302,272 shares at $22.00 per share. The shares will start trading on the NYSE under the symbol DNB on July 1, 2020, with the offering closing on July 6, 2020, pending customary conditions. The underwriters hold an option for an additional 11,745,340 shares. Concurrently, Cannae Holdings, Black Knight, and CC Capital will invest $400 million in private placements. Proceeds will be used to redeem Series A Preferred Stock, repay Senior Unsecured Notes, and for general corporate purposes.
Dun & Bradstreet has launched its initial public offering (IPO) of 65,750,000 shares at an estimated price of $19.00 to $21.00 per share. The company plans to grant underwriters a 30-day option to purchase an additional 9,862,500 shares. Concurrently, subsidiaries of Cannae, Black Knight, and CC Capital Partners will invest $400 million in a private placement contingent on the IPO. Proceeds will be used to redeem Series A Preferred Stock and repay a portion of Senior Unsecured Notes due in 2027.